Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Approaches aimed at enhancement of the tumor specific response have provided proof for the rationale of immunotherapy in cancer, both in animal models and in humans. Ipilimumab, an anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) antibody, is a new generation immunotherapeutic agent that has shown activity in terms of disease free and overall surviva...
Alternative Titles
Full title
Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0a9df570477b4280936d18c979b342bd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0a9df570477b4280936d18c979b342bd
Other Identifiers
ISSN
1178-7015
E-ISSN
1178-7015
DOI
10.2147/CCID.S24246
